Skip to main content

The FDA just granted approval to a fast-growing genetically modified salmon species

genetically modfied salmon gains approval fda 9390772 l
Image used with permission by copyright holder
In a move sure to bring the arguments over GMOs back to the forefront, the Food and Drug Administration on Thursday gave approval to a specific breed of genetically modified salmon — the first genetically modified animal to ever be approved by the agency. AquaBounty Technologies first submitted the concept for approval in 1995, however the FDA took the past two decades to deliberate the salmon’s safety and potential effects on the environment.

Officials said in a letter to AquaBounty president and CEO Ronald Stotish that it found no safety issues or negative environmental effects. Furthermore, the FDA has determined that the so-called “AquaAdvantage Salmon” is safe to eat, a statement sure to stoke the ire of anti-GMO activists. There are some conditions on the approval however, including a requirement that the GMO salmon must be kept in inland storage tanks.

So what exactly is an AquaAdvantage Salmon? According to the company’s website, it’s a genetic cross between Atlantic and Chinook breeds. The DNA of the fish is further modified to give it the capability to grow to full size in half the time it takes traditional Atlantic salmon to do so. AquaBounty further argues that its fish require a quarter less feed due to their shorter maturation period, and have less of a carbon footprint because the fish are raised in the US and have a shorter trip to market.

What may concern some is the lack of any requirement to label AquaBounty’s salmon as genetically modified. The FDA did not find any differences between traditional salmon and AquaBounty’s, so the company will not have to label it as such. “Because the data and information evaluated show that AquAdvantage Salmon is not materially different from other Atlantic salmon, the FDA has determined that no additional labeling of food from AquaAdvantage Salmon is required,” the FDA says on its website.

That isn’t enough for anti-GMO activists. Center for Food Safety director Andrew Kimbrell says that his group plans to file suit in order to block the approval.

“The review process by FDA was inadequate, failed to fully examine the likely impacts of the salmon’s introduction, and lacked a comprehensive analysis. This decision sets a dangerous precedent, lowering the standards of safety in this country,” he argues. Kimbrell further says the agency did not act in the best interests of the American public, and ignored research that called many of AquaBounty’s claims into question.

Editors' Recommendations

Ed Oswald
For fifteen years, Ed has written about the latest and greatest in gadgets and technology trends. At Digital Trends, he's…
This AI cloned my voice using just three minutes of audio
acapela group voice cloning ad

There's a scene in Mission Impossible 3 that you might recall. In it, our hero Ethan Hunt (Tom Cruise) tackles the movie's villain, holds him at gunpoint, and forces him to read a bizarre series of sentences aloud.

"The pleasure of Busby's company is what I most enjoy," he reluctantly reads. "He put a tack on Miss Yancy's chair, and she called him a horrible boy. At the end of the month, he was flinging two kittens across the width of the room ..."

Read more
Digital Trends’ Top Tech of CES 2023 Awards
Best of CES 2023 Awards Our Top Tech from the Show Feature

Let there be no doubt: CES isn’t just alive in 2023; it’s thriving. Take one glance at the taxi gridlock outside the Las Vegas Convention Center and it’s evident that two quiet COVID years didn’t kill the world’s desire for an overcrowded in-person tech extravaganza -- they just built up a ravenous demand.

From VR to AI, eVTOLs and QD-OLED, the acronyms were flying and fresh technologies populated every corner of the show floor, and even the parking lot. So naturally, we poked, prodded, and tried on everything we could. They weren’t all revolutionary. But they didn’t have to be. We’ve watched enough waves of “game-changing” technologies that never quite arrive to know that sometimes it’s the little tweaks that really count.

Read more
Digital Trends’ Tech For Change CES 2023 Awards
Digital Trends CES 2023 Tech For Change Award Winners Feature

CES is more than just a neon-drenched show-and-tell session for the world’s biggest tech manufacturers. More and more, it’s also a place where companies showcase innovations that could truly make the world a better place — and at CES 2023, this type of tech was on full display. We saw everything from accessibility-minded PS5 controllers to pedal-powered smart desks. But of all the amazing innovations on display this year, these three impressed us the most:

Samsung's Relumino Mode
Across the globe, roughly 300 million people suffer from moderate to severe vision loss, and generally speaking, most TVs don’t take that into account. So in an effort to make television more accessible and enjoyable for those millions of people suffering from impaired vision, Samsung is adding a new picture mode to many of its new TVs.
[CES 2023] Relumino Mode: Innovation for every need | Samsung
Relumino Mode, as it’s called, works by adding a bunch of different visual filters to the picture simultaneously. Outlines of people and objects on screen are highlighted, the contrast and brightness of the overall picture are cranked up, and extra sharpness is applied to everything. The resulting video would likely look strange to people with normal vision, but for folks with low vision, it should look clearer and closer to "normal" than it otherwise would.
Excitingly, since Relumino Mode is ultimately just a clever software trick, this technology could theoretically be pushed out via a software update and installed on millions of existing Samsung TVs -- not just new and recently purchased ones.

Read more